羟苯基丙酮酸双加氧酶是UTX缺陷结直肠癌的代谢免疫检查点
该研究利用UTX条件敲除小鼠和UTX沉默的MC38细胞,结合飞行时间质谱流式细胞术和代谢组学,揭示UTX缺陷结直肠癌细胞与髓源性抑制细胞(MDSC)之间由酪氨酸介导的代谢共生。UTX缺失导致苯丙氨酸羟化酶甲基化而免于降解,增加酪氨酸合成与分泌;MDSC摄取酪氨酸后经羟苯基丙酮酸双加氧酶代谢为尿黑酸,尿黑酸使STAT3抑制蛋白(PIAS3)Cys176羰基化,解除PIAS3对STAT5转录活性的抑制,促进MDSC存活与积聚,使结直肠癌细胞获得侵袭和转移特性。结论提示羟苯基丙酮酸双加氧酶可作为限制免疫抑制性MDSC、对抗UTX缺陷结直肠癌恶性进展的代谢检查点。
要点
- UTX缺陷结直肠癌通过分泌酪氨酸与MDSC形成代谢共生。
- MDSC中羟苯基丙酮酸双加氧酶将酪氨酸代谢为尿黑酸。
- 尿黑酸羰基化PIAS3的Cys176,解除对STAT5的抑制。
核心结论
- 羟苯基丙酮酸双加氧酶可作为代谢检查点限制免疫抑制性MDSC并对抗UTX缺陷结直肠癌的恶性进展。
研究设计与样本
- 使用UTX条件敲除小鼠和UTX沉默的MC38细胞研究UTX在结直肠癌发生发展中的功能。
- 采用飞行时间质谱流式细胞术阐明UTX在重塑结直肠癌免疫微环境中的作用。
- 通过分析代谢组学数据鉴定UTX缺陷癌细胞分泌并被MDSC摄取的代谢物。
主要发现
- UTX缺失导致苯丙氨酸羟化酶甲基化,阻止其降解,进而增加酪氨酸合成与分泌。
- MDSC摄取的酪氨酸经羟苯基丙酮酸双加氧酶代谢为尿黑酸。
- 尿黑酸通过羰基化Cys176修饰PIAS3,解除PIAS3对STAT5转录活性的抑制。
- 上述过程促进MDSC存活与积聚,使结直肠癌细胞获得侵袭和转移特性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Aberrant epigenetic events mediated by histone methyltransferases and demethylases contribute to malignant progression of colorectal cancer (CRC). However, the role of the histone demethylase ubiquitously transcribed tetratricopeptide repeat on chromosome X (UTX) in CRC remains poorly understood. METHODS: UTX conditional knockout mice and UTX-silenced MC38 cells were used to investigate UTX function in tumorigenesis and development of CRC. We performed time of flight mass cytometry to clarify the functional role of UTX in remodeling immune microenvironment of CRC. To investigate metabolic interaction between myeloid-derived suppressor cells (MDSCs) and CRC, we analyzed metabolomics data to identify metabolites secreted by UTX-deficient cancer cells and taken up by MDSCs. RESULTS: We unraveled a tyrosine-mediated metabolic symbiosis between MDSC and UTX-deficient CRC. Loss of UTX in CRC resulted in methylation of phenylalanine hydroxylase, preventing its degradation and subsequently increasing tyrosine synthesis and secretion. Tyrosine taken up by MDSCs was metabolized to homogentisic acid by hydroxyphenylpyruvate dioxygenase. Homogentisic acid modified protein inhibitor of activated STAT3 via carbonylation of Cys 176, and relieved the inhibitory effect of protein inhibitor of activated STAT3 on signal transducer and activator of transcription 5 transcriptional activity. This in turn, promoted MDSC survival and accumulation, enabling CRC cells to acquire invasive and metastatic traits. CONCLUSIONS: Collectively, these findings highlight hydroxyphenylpyruvate dioxygenase as a metabolic checkpoint to restrict immunosuppressive MDSCs and to counteract malignant progression of UTX-deficient CRC.
引用
- Du Z, Su J, Lin S, et al. Hydroxyphenylpyruvate Dioxygenase Is a Metabolic Immune Checkpoint for UTX-deficient Colorectal Cancer. Gastroenterology. 2023. PMID: 36813208. doi:10.1053/j.gastro.2023.02.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。